The SANTO company, a leader in Kazakhstan’s pharmaceutical market, revealed plans for its research&development (R&D) hub, the company’s scientific laboratory and the plant, which manufactures a diverse range of medicines up to par with European standards of quality, the company’s press service reported on Nov. 2.
According to SANTO Director of...
